Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome

Open access
Jakobsson, Hedvig E., Jernberg, Cecilia, Andersson, Anders F., Sjölund-Karlsson, Maria, Jansson, Janet K., Engstrand, Lars · 2010 · PLoS ONE

Abstract

Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer. However, the long-term consequences of this treatment on the human indigenous microbiota are relatively unexplored. Here we studied short- and long-term effects of clarithromycin and metronidazole treatment, a commonly used therapy regimen against H. pylori, on the indigenous microbiota in the throat and in the lower intestine. The bacterial compositions in samples collected over a four-year period were monitored by analyzing the 16S rRNA gene using 454-based pyrosequencing and terminal-restriction fragment length polymorphism (T-RFLP). While the microbial communities of untreated control subjects were relatively stable over time, dramatic shifts were observed one week after antibiotic treatment with reduced bacterial diversity in all treated subjects in both locations. While the microbiota of the different subjects responded uniquely to the antibiotic treatment some general trends could be observed; such as a dramatic decline in Actinobacteria in both throat and feces immediately after treatment. Although the diversity of the microbiota subsequently recovered to resemble the pre treatment states, the microbiota remained perturbed in some cases for up to four years post treatment. In addition, four years after treatment high levels of the macrolide resistance gene erm(B) were found, indicating that antibiotic resistance, once selected for, can persist for longer periods of time than previously recognized. This highlights the importance of a restrictive antibiotic usage in order to prevent subsequent treatment failure and potential spread of antibiotic resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0009836

Cites

0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Phyla distribution in throat samples. Pie charts showing the phyla found in throat samples at day 0, day 8–13, 1 and 4 years in three controls (A, B, and C) and three antibiotic treated patients (D, E, and F). By using 16S rRNA pyrosequencing five different phyla were found in the throat samples; Firmicutes, Proteobacteria, Actinobacteria, Bacteroidetes, and Fusobacteria.
Figure 1 Phyla distribution in throat samples. Pie charts showing the phyla found in throat samples at day 0, day 8–13, 1 and 4 years in three controls (A, B, and C) and three antibiotic treated patients (D, E, and F). By using 16S rRNA pyrosequencing five different phyla were found in the throat samples; Firmicutes, Proteobacteria, Actinobacteria, Bacteroidetes, and Fusobacteria.CC BY · PubMed Central
Figure 2 Phyla distribution in fecal samples. Pie charts showing the phyla found in fecal samples at day 0, day 8–13, 1 and 4 years in three controls (A, B, and C) and three antibiotic treated patients (D, E, and F). By using 16S rRNA pyrosequencing four different phyla were found in fecal samples; Firmicutes, Proteobacteria, Actinobacteria, and Bacteroidetes.
Figure 2 Phyla distribution in fecal samples. Pie charts showing the phyla found in fecal samples at day 0, day 8–13, 1 and 4 years in three controls (A, B, and C) and three antibiotic treated patients (D, E, and F). By using 16S rRNA pyrosequencing four different phyla were found in fecal samples; Firmicutes, Proteobacteria, Actinobacteria, and Bacteroidetes.CC BY · PubMed Central
Figure 3 Individualized antibiotic responses. The heat maps show the relative abundance per sample of different taxonomic groups found in throat (A) or fecal (B) patient samples. The color panel shows the percent relative abundance (0–70%) of different taxonomic groups within the major phyla (Actinobacteria, Bacteroidetes, Firmicutes, Fusobacterium and Proteobacteria) detected from patients at day 0 (1), day 8–13 (2), 1 year (3) and 4 years (4) after treatment.
Figure 3 Individualized antibiotic responses. The heat maps show the relative abundance per sample of different taxonomic groups found in throat (A) or fecal (B) patient samples. The color panel shows the percent relative abundance (0–70%) of different taxonomic groups within the major phyla (Actinobacteria, Bacteroidetes, Firmicutes, Fusobacterium and Proteobacteria) detected from patients at day 0 (1), day 8–13 (2), 1 year (3) and 4 years (4) after treatment.CC BY · PubMed Central
Figure 4 Correlation plots for the controls. Correlation plots showing OTU frequency at day 0 (x-axis), and day 8–13, 1 and 4 years (y-axis) in throat (A) and fecal (B) samples in the controls (A, B, and C). Bray-Curtis values are indicated as numbers in the figure as a number. A Bray Curtis value of 0 suggest the two sites have the same composition and 1 means the two sites do not share any species. The color of the dots represent different phyla: yellow, Actinobacteria; green, Bacteroidetes; blue, Firmicutes; red, Proteobacteria; grey, other phyla. Percentages of inter-sample variation explained by the two axes are shown in the figures.
Figure 4 Correlation plots for the controls. Correlation plots showing OTU frequency at day 0 (x-axis), and day 8–13, 1 and 4 years (y-axis) in throat (A) and fecal (B) samples in the controls (A, B, and C). Bray-Curtis values are indicated as numbers in the figure as a number. A Bray Curtis value of 0 suggest the two sites have the same composition and 1 means the two sites do not share any species. The color of the dots represent different phyla: yellow, Actinobacteria; green, Bacteroidetes; blue, Firmicutes; red, Proteobacteria; grey, other phyla. Percentages of inter-sample variation explained by the two axes are shown in the figures.CC BY · PubMed Central
Figure 5 Correspondence analysis of the bacterial community found in throat samples. Each correspondence analysis plot represents the relative abundance values for the OTUs from the 16S rRNA pyrosequencing at day 0, day 8–13, 1 and 4 years. A: Controls; A, B, and C. B: Antibiotic treated patients; D, E, and F. Percentages of inter-sample variation explained, by the two axes are shown in the figures. In controls A–C and patients D–F the third axis represented 25%, 27%, 26%, 22%, 24%, and 20% of the variation.
Figure 5 Correspondence analysis of the bacterial community found in throat samples. Each correspondence analysis plot represents the relative abundance values for the OTUs from the 16S rRNA pyrosequencing at day 0, day 8–13, 1 and 4 years. A: Controls; A, B, and C. B: Antibiotic treated patients; D, E, and F. Percentages of inter-sample variation explained, by the two axes are shown in the figures. In controls A–C and patients D–F the third axis represented 25%, 27%, 26%, 22%, 24%, and 20% of the variation.CC BY · PubMed Central
Figure 6 Correspondence analysis of the bacterial community found in fecal samples. Each correspondence analysis plot represents the relative abundance values for the OTUs from the 16S rRNA pyrosequencing at day 0, day 8–13, 1 and 4 years. A: Controls; A, B, and C. B: Antibiotic treated patients; D, E, and F. Percentages of inter-sample variation explained, by the two axes are shown in the figures. In controls A–C and patients D–F the third axis represented 19%, 17%, 20%, 26%, 20%, and 20% of the variation.
Figure 6 Correspondence analysis of the bacterial community found in fecal samples. Each correspondence analysis plot represents the relative abundance values for the OTUs from the 16S rRNA pyrosequencing at day 0, day 8–13, 1 and 4 years. A: Controls; A, B, and C. B: Antibiotic treated patients; D, E, and F. Percentages of inter-sample variation explained, by the two axes are shown in the figures. In controls A–C and patients D–F the third axis represented 19%, 17%, 20%, 26%, 20%, and 20% of the variation.CC BY · PubMed Central
Figure 7 Correlation plots for the patients. Correlation plots showing OTU frequency at day 0 (x-axis), day 8–13, 1 and 4 years (y-axis) in throat (A) and fecal (B) samples in the patients (D, E, and F). Bray-Curtis values are indicated as numbers in the figure. A Bray Curtis value of 0 suggest the two sites have the same composition and 1 that the two sites do not share any species. The colors of the dots represent different phyla: yellow, Actinobacteria; green, Bacteroidetes; blue, Firmicutes; red, Proteobacteria; grey, other phyla.
Figure 7 Correlation plots for the patients. Correlation plots showing OTU frequency at day 0 (x-axis), day 8–13, 1 and 4 years (y-axis) in throat (A) and fecal (B) samples in the patients (D, E, and F). Bray-Curtis values are indicated as numbers in the figure. A Bray Curtis value of 0 suggest the two sites have the same composition and 1 that the two sites do not share any species. The colors of the dots represent different phyla: yellow, Actinobacteria; green, Bacteroidetes; blue, Firmicutes; red, Proteobacteria; grey, other phyla.CC BY · PubMed Central
Figure 8 erm(B) abundance over time. The normalized fold increase of erm(B) compared to day 0 in community DNA extracted from fecal samples for controls (A–C) not receiving any treatment (A) and patients (D–F) receiving antibiotics (B). Each bar graph represents the mean and standard error of the normalized expression of erm(B) compared to 16S. Normalization was carried out as previously been described [8].
Figure 8 erm(B) abundance over time. The normalized fold increase of erm(B) compared to day 0 in community DNA extracted from fecal samples for controls (A–C) not receiving any treatment (A) and patients (D–F) receiving antibiotics (B). Each bar graph represents the mean and standard error of the normalized expression of erm(B) compared to 16S. Normalization was carried out as previously been described [8].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

The publisher hasn’t deposited this paper’s reference list.

Research works printed but not linked: 1

  1. [45]Hayek LCaMAB 1996 Surveying natural populations. New York Columbia University Press

Cited by

See all 1,160

Metadata

Authors
Jakobsson, H. E., Jernberg, C., Andersson, A. F., Sjölund-Karlsson, M., Jansson, J. K., & Engstrand, L.
Affiliations
  • Swedish Institute (SE)
  • Uppsala University (SE)
  • Lawrence Berkeley National Laboratory (US)
Corresponding author
Engstrand, Lars
Venue
PLoS ONE
Published
2010-03-24
Volume
5
Issue
3
Pages
e9836
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1530269410
Cited by
1,160
References
0
Citations by year
2026: 35 · 2025: 46 · 2024: 77 · 2023: 73 · 2022: 88 · 2021: 114 · 2020: 88 · 2019: 95 · 2018: 117 · 2017: 79 · 2016: 83 · 2015: 67 · 2014: 73 · 2013: 57 · 2012: 41
FWCI
16.01
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of North Texas Digital Library (University of North Texas) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
  • Lawrence Berkeley National Laboratory
Funders
  • U.S. Department of Energy (-AC02-05CH11231, 05CH11231, DE AC02 05CH11231, DE-AC02-)
  • Ekhagastiftelsen
  • Lawrence Berkeley National Laboratory (AC02‐05CH11231, DE-AC02-05CH11231, 05CH11231)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
  • Physical Sciences › Environmental Science › Ecology › Microbial Community Ecology and Physiology
Keywords
Helicobacter pylori eradication, clarithromycin, metronidazole, antibiotic therapy, gut microbiota, microbial diversity, actinobacteria, macrolide resistance, ermB, peptic ulcer, gastric cancer
MeSH terms
Anti-Bacterial Agents, Drug Resistance, Microbial, Dyspepsia, Feces, Humans, Metronidazole, Oligonucleotides, Omeprazole, Pharynx, Phylogeny, Polymorphism, Restriction Fragment Length, RNA, Ribosomal, 16S, Time Factors, Case-Control Studies, Clarithromycin, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome. https://app.cochat.ai/papers/10.1371/journal.pone.0009836
The paper
Jakobsson, H. E., Jernberg, C., Andersson, A. F., Sjölund-Karlsson, M., Jansson, J. K., & Engstrand, L. (2010). Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome. PLoS ONE. https://doi.org/10.1371/journal.pone.0009836

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.